← SearchCPVOD-19 DEVELOPMENT OF DF-COV FOR THE TREATMENT AND PREVENTION OF COVID-19 AND ASSOCIATED IMMUNOPATHOLOGIC RESPIRATORY COMPLICATIONS$6,881,254FY2021Defense Health AgencyDODDana-Farber Cancer Institute, Inc.InvestigatorsView source on USAspending →